MicroRNAs in Non-small Cell Lung Cancer: Current Status and Future Therapeutic Promises

E-ISSN： 1873-4286|20|24|3982-3990

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.20, Iss.24, 2014-05, pp. : 3982-3990

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Bonafide Targets of Deregulated microRNAs in Non-Small Cell Lung Cancer as Tool to Identify Novel Therapeutic Targets: A Review

Current Pharmaceutical Design, Vol. 23, Iss. 1, 2017-02 ,pp. : 55-72

Bentham Science Publishers

Access to resources Recommend Favorite

Regulation Mechanism of MicroRNAs in Non-Small Cell Lung Cancer

Current Pharmaceutical Design, Vol. 23, Iss. 39, 2018-02 ,pp. : 5973-5982

Bentham Science Publishers

Access to resources Recommend Favorite

Impact of microRNAs in Resistance to Chemotherapy and Novel Targeted Agents in Non-Small Cell Lung Cancer

Current Pharmaceutical Biotechnology, Vol. 15, Iss. 5, 2014-05 ,pp. : 475-485

Bentham Science Publishers

Access to resources Recommend Favorite

The Roles of microRNAs in Regulating Chemotherapy Resistance of Non-Small Cell Lung Cancer

Current Pharmaceutical Design, Vol. 23, Iss. 39, 2018-02 ,pp. : 5983-5988

Bentham Science Publishers

Access to resources Recommend Favorite

Neoadjuvant chemotherapy and chemoradiotherapy for non-small cell lung cancer: current status and future prospects

By Edelman Martin J

Expert Opinion on Pharmacotherapy, Vol. 4, Iss. 6, 2003-06 ,pp. : 843-852

Informa Healthcare

Access to resources Recommend Favorite